估算有资格使用免疫检查点抑制剂药物的美国癌症患者的百分比。
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for Immune Checkpoint Inhibitor Drugs.
机构信息
Division of Hematology and Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland.
Now with Center for Health Sciences, Oklahoma State University, Tulsa.
出版信息
JAMA Netw Open. 2020 Mar 2;3(3):e200423. doi: 10.1001/jamanetworkopen.2020.0423.
Abstract
This cross-sectional study estimates the percentage of US patients with cancer who are eligible for immune checkpoint inhibitor drugs.
摘要
本横断面研究估计了美国癌症患者中有资格使用免疫检查点抑制剂药物的比例。
Zotero 插件